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After infection w i t h unrelated viruses such as paramyxoviruses, orthomyxoviruses, 
poxviruses, and rhabdoviruses (1) mice generate cytolyt ic Τ lymphocytes ( C T L ) 1 that 
possess selective specificity for the sensitizing virus. However, after infection w i t h 
different subtypes o f serologically distinct influenza A viruses (2) at least more than 
one popula t ion o f C T L can be demonstrated. Both cross-reactive and subtype-specific 
lymphocytes can be distinguished (3-12). 
These cross-reactive effector Τ cells may lack the discr iminatory capacity for 
influenza antigens shown by the Β cell products, or they may recognize a shared 
antigenic determinant . Because the question o f the nature o f antigens recognized by 
Τ cells, as wel l as the structure and composition o f the Τ cell receptor, is not yet clear, 
the orthomyxoviruses offer a biological relevant system for the analysis o f Τ cell 
specificity. 
T h e subtypes o f influenza A viruses differ w i t h respect to the antigenici ty o f the 
envelope glycoproteins, hemagglut in in ( H A ) and neuraminidase (N) . H A and Ν are 
inserted in to the plasma membrane o f cells du r ing the b u d d i n g process that results in 
virus release from the infected cells (13, 14). The internal v i r ion components, the 
ma t r ix ( M ) protein and the r ibonucleoprotein (NP) , o f a l l influenza A viruses seem to 
be closely related antigenically. T h e cell-membrane expression o f antigens is a 
prerequisite for Τ cell recognition (15-17). The work o f several authors has therefore 
centered on the question of membrane expression o f these antigens. Μ protein has 
now been detected on the cell membrane, and, consequently, i t has been claimed that 
the cross-reactive Τ cell may recognize this protein (8, 18-22). 
Th i s study aims to clarify the role o f Μ protein in the C T L response. Target cells 
were prepared by two different methods. First by abortive infection o f L-929 cells 
* Supported by the Deutsche Forschungsgemeinschaft 571/5 and 571/7. 
1 Abbreviations used in this paper: Choi, cholesterol; C T L , cytolytic Τ lymphocytes; E M , electron micros­
copy; FPV, fowl plague virus; H A , hemagglutinin; H A U , hemagglutinating unit(s); M , matrix; M O I , 
multiplicity of infection; N , neuraminidase; NP, ribonucleoprotein; PBS, phosphate-buffered saline; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PFU, plaque-forming unit(s); PMSF, phenylmeth-
ylsulfonylfluoride; PS, L-phosphatidyl-L-serine; SDS, sodium dodecyl sulfate; SV, Sendai virus; T N , Tris-
buffered saline; TRY-SV, irypsin-inactivated SV. 
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w i t h an avian influenza A strain that expresses only the vira l envelope glycoproteins, 
H A and N , in the plasma membrane (23). Second, the H A and Ν glycoprotein o f the 
human influenza virus A / V i c t o r i a were separated from the other v i r ion components 
and reconstituted into art if icial l i p i d bilayers (24, 25) to give vesicles free o f Μ protein 
and NP. Target cells were then prepared by incubat ing these vesicles w i t h cells in the 
presence of fusion-active Sendai virus (26). Various influenza Α-specific C T L were 
tested against both types o f target cells. T h e results showed a s imilar pat tern o f cross-
reactivity w i t h that previously observed after infection o f cells w i t h different human 
influenza A virus subtypes. Thus target antigens recognized by cross-reactive C T L 
are not carried by Μ protein but by the glycoproteins H A or Ν in the plasma 
membrane. 
Materials and Methods 
Viruses. Sendai virus; the influenza viruses A/Asia/M/1468 (H2N2), A/PR/8 /34 (H0N1), 
A/Victoria/3/75 (H3N2), and B/Mass/71; and the avian influenza strains A/FPV/Rostock 
( H a v l / N l ) and A/Tur/Canada/63 (Hav6 Neq2) were used. Viruses were grown in the 
allantoic cavity of 11-d-old embryonated chicken eggs, and virus stocks were stored in the 
allantoic fluid at — 80°C. Plaque assays for the determination of plaque-forming units (PFU), 
titration of hemagglutinating units (HAU), Ν and hemolytic activities were carried out by 
established procedures (15). 
Purification of Sendai virus (SV), inactivation with ß-propiolactone, and digestion of trypsin-
inactivated SV (TRY-SV) to destroy the functional activity of the fusion protein were done as 
described previously (15, 17). 
Preparation of Influenza A Glycoprotein and Re constitution into Artificial Vesicles. Purified influenza 
A/Victoria was a gift from Searle Laboratories, London. Virus protein was determined by the 
Lowry method using bovine serum albumin standards. Influenza A/Victoria virus (10 mg/ml) 
was suspended in phosphate-buffered saline (PBS), without M g or Ca, that contained 2% 
Empigen BB (Albright & Wilson Ltd. , Detergents and Chemical Group, Whitehaven. England) 
and 1 m M phenylmethylsulfonylfluoride (PMSF) (Sigma Chemical Co., London). Preparation 
of tritium-labeled virus was carried out according to the method of Critchley (27). Disruption 
of virus and solubilization of glycoproteins was achieved by three separate 15-s sonications at 
setting 3 with a Branson sonicator probe (model 2530-IA, Branson Sonic Power Co., Danbury, 
Conn.) at 4°C. The disrupted virus was dialyzed overnight against 1 Μ Tris buffer (pH 6.8) 
that contained 2% Empigen BB, 1 m M PMSF, and 100 m M sodium azide. The preparation 
(25 mg unlabeled virus in 4 ml and 200 μg of tritium-labeled virus) was then layered onto a 
sucrose gradient that consisted of three zones similar to that described by Helenius et al. (24): 
A 2-ml 10% sucrose zone that contained 2% Empigen BB on top, a 30-ml linear 15-30% sucrose 
gradient that contained 1% Empigen BB in the middle, and a 2-ml 50% (wt/vol) sucrose 
cushion in Tris-buffered saline (TN) buffer (pH 7.4) at the bottom. 
After centrifugation (40 h, 4°C, 25,000 rpm) in a Beckman SW 27 rotor (Beckman 
Instruments Inc., Spinco Div., Palo Alto, Cal i f ) , fractions were collected from the bottom and 
assayed for radioactivity and protein concentration. The protein-containing fractions were 
analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis by the method of 
Laemmli (28) with 10% gels. Two-dimensional gel electrophoresis was carried out according to 
the method of Wang and Richards (29). Fractions that contained only the envelope glycopro­
teins were used for reconstitution. Reconstitution was done according to a protocol developed 
for reconstitution of SV envelope proteins (M.-J. Gething. Unpublished observations.): The 
lipids L-phosphatidyl-L-serine (PS) (10 mg/ml) (Sigma Chemical Co.); phosphatidylethanola-
mine (ΡΕ) (1 mg/ml) (BDH Chemicals Ltd. , Poole, England); phosphatidylcholine (PC) (10 
mg/ml) (Sigma Chemical Co.); and cholesterol (Choi) (10 mg/ml) (Sigma Chemical Co.) that 
were suspended in chloroform:methanol 95:5 (vol/vol) were used. Lipids were mixed in the 
ratio of 2 PE:1 PS:1 PC:1 Choi in 30-ml tubes, and the chloroform and methanol were 
evaporated under nitrogen, washed twice with the same volume of diethylether, and dried 
under nitrogen to obtain a thin lipid film. The film was dissolved in T N buffer that contained 
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1 m M PMSF, 2 m M CaCL, 2 m M MgCl 2 , and 1% Empigen BB by heating for 30 s at 100°C. 
The detergent-purified HA and Ν viral glycoproteins in T N buffer that contained 1% Empigen 
BB were added. Reconstitution was achieved by detergent dilution (24). The detergent was 
diluted by stepwise addition of T N buffer over a period of 5 h. A control preparation of HA 
and Ν was also made without lipid. The reconstituted HA and Ν vesicles were concentrated by 
centrifugation (15 h, 20°C, 38,000 rpm, 8- X 50-ml MSE Rotor, MSE Scientific Instruments, 
Manor Royal, Crawley, Sussex, England). The pellet was resuspended in T N buffer and 
analyzed by Polyacrylamide gel electrophoresis and electron microscopy. 
Mice. Female C 3 H (H-2K), CBA/J (H-2K), C 3 H O H (H-2°), and DBA/2/Den (H-2 d) mice 
were bred at the German Cancer Research Center, Heidelberg, Federal Republic of Germany 
or purchased from Ry Bomholtgard, Copenhagen, Denmark, and used at 8-12 wk of age. Mice 
were immunized by single inoculation of 200-400 H A U i.p. of virus. Effector-cell generation by 
secondary challenge with homologous virus in vitro was done as described previously (15, 17, 
30, 31). Spleen cells from mice primed 3 -6 wk before testing were cultured in the presence of 
stimulator cells at a ratio of 10:1 for 5-7 d in RPMI-1640 medium supplemented with 
antibiotics, 2 X 10~5 Μ 2-mercaptoethanol, and 10% heat-inactivated fetal calf serum (Grand 
Island Biological Co., Grand Island, Ν. Y.). Stimulator cells were prepared by incubation of 
syngeneic spleen cells with 1-10 H A U of virus/10 6 cells for 60 min followed by a threefold 
washing of cells. 
Cytolytic Assay. P-815 (H-2 d) and L-929 (H-2 k) cells were grown in tissue culture. For target-
cell formation with influenza viruses, 106 cells were incubated either with 200 H A U of virus or 
with preparations that contained known amounts of PF'U. After 60 min, virus adsorption cells 
were washed three times and labeled with 5 l C r for a further 3 h. Target cells prepared with 
inactivated SV and TRY-SV were obtained as described before (17). Preparation of target cells 
with vesicles was carried out as previously described (26): Influenza vesicles were bound to cells 
by incubation of 106 cells with 30 μg of vesicles for 4 h. Fusion of influenza A vesicles that 
contained HA and Ν was achieved by coincubation of cells with 30 μg of vesicles and 10 μg of 
fusion-active SV for 4 h. A control for fusion was carried out with the same amount of TRY-
SV. In the cytolytic assay, target cells were incubated with C T L at four effector:target ratios. 
After a 4-h incubation at 37 °C in 5% C O 2 atmosphere, supernates were harvested and the 
specific release was determined as percent specific 5 1 Cr release = (release by effector cells — 
spontaneous release/maximal release — spontaneous release) X 100. Spontaneous release was 
determined from target cells incubated with medium only, and maximal release from target 
cells incubated with 2% SDS in PBS. Al l values are the mean percent specific 5 1 Cr release of at 
least three wells. 
Resul ts 
Abortively Infected Targets Devoid of Μ Protein Are Lysed by Cross-Reactive CTL. I n L -
929 cells infected w i t h influenza A / f o w l plague virus (FPV) the synthesis o f Μ protein 
does not occur, a l though the virus-specific glycoproteins are synthesized and incor­
porated into the plasma membrane (23). This system was used to determine the role 
of the Μ protein as an antigen recognized by cross-reactive influenza A strain-specific 
C T L . L-929 target cells infected w i t h 10 P F U / c e l l o f A / F P V were incubated w i t h 
secondary C T L of C B A mice sensitized i n vivo and restimulated in v i t ro w i t h F P V , 
A / A s i a , P R / 8 , A / T u r k e y , or B/Mass. As expected, lysis was seen after addi t ion o f 
effector cells that had specificity for F P V (Fig. 1). However, the all-influenza-type-A-
pr imed effector cells in addi t ion to the effect on homologous targets also lysed the L -
929 target cells infected w i t h FPV. O n l y effector cells w i t h specificity for B/Mass 
failed to lyse the L-929 F P V targets. This pat tern o f cross-reactivity that has been 
observed by other authors (3, 5, 7, 9) was also found when influenza A target cells 
that lacked Μ protein were used. 
T o exclude involvement o f Μ protein from the virions used for cell infection, the 
fol lowing experiment was carried out: L-929 cells were infected w i t h F P V at a 
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FIG. 1. Effect of influenza subtype-specific C T L on L-929 target cells abortively infected with 1 0 
PFU/FPV cell. C T L were primed and restimulated with the homologous virus strain and tested on 
target cells infected with the sensitizing virus or with FPV. Target cells: ( O ) noninfected L-929; 
( · ) L-929 infected with A / F P V ; ( • ) L-929 infected with A/Turkey; ( • ) L-929 infected with A / 
Asia: (Δ) L-929 infected with A / P R / 8 ; (A) L-929 infected with B/Mass. 
m u l t i p l i c i t y of infection ( M O I ) o f 0.01-100 P F U / c e l l and tested after a 4-h or 
overnight incubat ion after infection. Effector cells were secondary C 3 H . O H C T L 
w i t h specificity for A / A s i a . Fig. 2 shows that the same cross-reactivity pat tern was 
observed at the M O I of 1 PFU/ce l l , wh ich is too low to obta in lysable target cells 
after 4 h o f infection, and 16 h o f synthesis o f v i ra l glycoproteins is required for Τ cell-
mediated lysis. Therefore, the Μ protein transported into the target cell du r ing the 
process o f penetration can not explain the cross-reactivity observed. 
Reconstitution of Membrane Glycoproteins HA and Ν in Lipid Vesicles. Influenza A / 
V i c t o r i a virus was solubilized by sonication in detergent. The solubilized virus was 
centrifuged into a sucrose gradient in detergent. T h e spike proteins, H A and N , were 
recovered as a broad band in the upper part o f the gradient; whereas N P was found 
i n the bo t tom fractions and Μ protein and l ipids at the top o f the gradient. T h e 
fractions were analyzed by Polyacrylamide gel electrophoresis, and the composit ion o f 
the fractions used for reconstitution is shown i n Fig. 3 A and B. I t is shown i n two-
dimensional gel that the high molecular proteins on the top o f the gels contain tr imers 
and dimers o f H A as well as N , but no N P or Μ protein. 
Lipid-free H A and Ν w i l l not interact w i t h cells to produce lysable targets (26), 
presumably because these integral viral membrane proteins are no longer correctly 
oqentated i n a l i p i d bilayer. T o m i m i c the normal mode o f presentation o f these 
glycoproteins, the H A and Ν were reconstituted in l i p i d vesicles and integrated in to 
the target cell membrane obtained by fusion. 
T h e lipids PE, PS, PC, and Cho i were solubilized in the detergent-solubilized 
proteins. T h e detergent concentration was reduced ~50-fo ld by stepwise d i l u t i o n . T h e 
reconstituted material was analyzed by electron microscopy. The glycoproteins were 
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FIG. 2. Effect of virus concentration and viral protein synthesis on antigen formation recognized 
by cross-reactive C T L . Effector cells were C3H.OH lymphocytes primed in vivo and restimulated 
in vitro with A/Asia. Target cells were prepared by incubation of L-929 cells with different P F U / 
cell (number of P F U shown in each box) for ( • ) 4 h or ( · ) 16 h. CO, uninfected targets. 
H A 2 
FIG. 3. (A) Polyacrylamide gel electrophoresis in SDS under nonreduced conditions of A/Victor ia 
virus proteins, after gradient centrifugation and after reconstitution. Left lane: A/Victor ia virus; 
middle lane: fraction with peak radioactivity and glycoprotein concentration; right lane: reconsti-
tuted preparation. (B) Two-dimensional gel of A/Victor ia virus proteins. First dimension: Laemmli 
tube gel (5% stack, 10% running gels). Second dimension: under reduced conditions performed 
according to Wang and Richards (29). After splitting by reductive cleavage during the initial phase 
of the second-dimension slab gel, the molecule complexes are identified by their off-diagonal position 
on the final pattern. (HA)] , FIA monomers; (HA)2, MA dimcrs: (HA).), H A trimers. 
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FIG. 4 . Electronmicroscopy of reconstituted vesicles. X 120,000. 
observed as distinct spikes, the majori ty o f which were associated w i t h uni lamel lar 
vesicles that ranged in size from 10 to 50 n M (Fig. 4). Some vesicles were round or 
oval, whereas others were extended and irregular but enclosed by a l i p i d bilayer. A 
background of what are probably free spikes or rosettes o f lipid-free spikes was also 
seen. The packing o f spikes was similar to that observed on virus particles and it 
appeared that the spikes were orientated so that they projected outwards from the 
l i p i d bilayer. This ou tward orientat ion is supported by the observation that reconsti­
tuted vesicles showed 10- to 100-fold greater hemagglut inat ing act ivi ty than glyco-
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FIG. 5. Target cell formation with influenza envelope proteins reconstituted into lipid vesicles. 
Target ceils were prepared by incubation of 106 L-929 cells with 10 μg /?-propiolactone-inactivated 
SV, with 10 ^g SV with enzymatically inactivated fusion protein (TRY-SV 7), 100 H A U influenza 
A/Victoria , 30 μg reconstituted envelope proteins of A/Victoria-virus vesicles (A/VIC-VES) , or 
with mixtures of reconstituted vesicles with SV preparations. Incubation time of cells with virus was 
4 h at 37°C. Targets were incubated with effector cells with specificity for either SV or influenza A / 
Victoria ( A / V I C ) . 
proteins that were carried through the reconstitution procedure in the absence o f 
l i p i d . Such preparations contained rosettes and free glycoprotein spikes w i t h no sign 
o f vesicle formation (data not shown). 
Target-Cell Formation with Influenza A/Victoria Glycoproteins Incorporated into 
Vesicles. A l though vesicles that contain H A and Ν attach to target cells, fusion does 
not seem to occur. Thus we have used a recently developed method to prepare target 
ceils w i t h reconstituted Semliki forest virus membrane vesicles (26). Influenza A / 
V ic to r i a vesicles were incubated w i t h 5 1 Cr-labeled L-929 cells in the absence or 
presence of noninfectious /?-propiolactone-treated, fusion-active SV or T R Y - S V that 
was no longer capable o f causing fusion. As control targets, noninfected L-929 cells, 
L-929 cells infected w i t h influenza A / V i c t o r i a , or L-929 cells incubated w i t h the two 
preparations of SV were used. Antigen-specific Τ cell-mediated cytolysis was tested 
by the addi t ion to these targets o f either SV-specific C T L or influenza A / V i c t o r i a -
specific C T L (Fig. 5). Target cells prepared w i t h T R Y - S V were not susceptible to 
lysis, presumably as a result o f the loss o f fusion act ivi ty (17). S imi lar ly , the targets 
incubated w i t h influenza A / V i c t o r i a vesicles alone or together w i t h T R Y - S V showed 
a low level o f lysis, which indicated that the mere presence o f SV antigens is not 
sufficient to form influenza-specific target cells w i t h vesicles. However, target cells 
incubated w i t h the vesicles and fusion-active SV were lysed by both the influenza-
specific C T L and the SV-specific C T L . The specificity o f influenza A / V i c t o r i a C T L 
in this reaction is selectively directed to influenza A / V i c t o r i a antigens, and there is no 
evidence to support the idea that SV antigens are recognized by these effector cells. 
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FIG. 6. Cytolytic activity of various influenza- and V-specific C T L on artificial target cells 
prepared with reconstituted virosomes. Target L-929 cells incubated with ( · ) A/Victoria-vesicles 
and SV (Fig. 5 legend); (A) A/Victor ia ; ( B ) V P V ; ( • ) A/Asia; ( • ) A / P R / 8 ; (O) B/Mass.; (Δ) SV; 
(O) noninfccted L-929 control. 
Cross-Reactive CTL Specific for Different Subtypes of Influenza A Recognize Antigens of the 
Influenza A/Victoria Envelope Proteins. H a v i n g established a method to test target cells 
prepared w i t h the envelope proteins, a variety o f effector cells specific for different 
influenza subtypes were tested. C T L w i t h specificity for F P V , A / A s i a , A / P R 8 , A / 
Vic tor ia , and B/Mass. were tested on targets infected w i t h homologous or heterologous 
virus or on targets prepared w i t h reconstituted vesicles that contained only the H A 
and Ν glycoproteins o f A / V i c t o r i a . Target cells incubated w i t h S V served as a control . 
The results are shown in Fig. 6. There was no cross-reactivity between influenza A -
and influenza B-specific effector cells. Specific lysis was demonstrated on the homol­
ogous targets and cross-reactive lysis to various degrees on the heterologous target 
cells. Effector cells that showed cross-reactivity for target cells infected w i t h A / 
Vic to r ia also produced significant lysis o f target ceils prepared w i t h reconstituted 
vesicles that contained only the H A and Ν glycoproteins. Thus , antigen recognition 
by cross-reactive Τ cells is independent of the presence o f Μ protein. 
Lysis of Artificial Target Cells is H-2 Restricted. T o conf i rm the observation that 
recognition o f the ar t i f ic ial target cells is mediated by processes similar to those o f 
targets prepared by infection the H-2 restriction o f the cytolyt ic interaction was tested. 
Effector cells o f the haplotypes H - 2 b and H - 2 k were tested on the appropriate target 
cells as well as on art if icial cells prepared by fusion w i t h A / V i c t o r i a vesicles. Table I 
shows that the H-2-restriction rule also applies to the target cells prepared w i t h 
art if icial vesicles. 
Discuss ion 
The aim of this study was to define the molecules that carry the specificities 
recognized by cross-reactive C T L that lyse target cells infected w i t h serologically 
different influenza A subtypes. By using two types o f target cells, bo th devoid o f Μ 
protein, we found that cross-reactive Τ cells recognize antigens o f the envelope 
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T A B L E I 
H-2 Restriction of Cross-Reactivity Against Target Cells Prepared with A/ 
Victoria Virus Vesicles 
Target 
Effector cell P-815-A/ 
Asia 
£ 8 1 5 - A / L-929-A/ Vic-ves 4- A . 
sv* A s i a 
L-929-A/ 
Vic-ves + 
SV 
DBA/2-A/Asia 
CBA-A/Asia 
68.5 
4.3 
% 
32.6 
5.6 
3.2 
45.4 
4.8 
22.3 
Effector cells are derived from spleen cells of mice primed with A/Asia and 
restimulated in vitro for 6 d with A/Asia-infected syngeneic stimulator cells. 
The effector:target ratio was 25:1. 
* Vic-ves, A/Victor ia virus vesicles. 
glycoproteins H A and Ν of influenza A viruses. This is i n contrast to previous work 
that indicated a major role for Μ protein in p rov id ing the cross-reactive target 
antigen. 
Μ protein, which is antigenically similar i n al l influenza A strains, was considered 
to be the candidate for the cross-reactive antigen seen by these Τ cells because recent 
studies have demonstrated that the Μ protein may be detected on the surface o f 
infected cells (18-21). Braciale (8) has investigated the Μ protein specificity o f C T L 
by interfering w i t h the process o f glycosylation. By showing that 2-deoxyglucose 
treatment o f target cells had (a) no effect on Μ prote in expression and (b) changed 
the competi t ion pattern of cold target cells infected w i t h homologous or heterologous 
influenza A subtypes, he concluded that the cross-reactive target antigen is a nongly-
cosylated protein and, therefore, perhaps, the Μ protein. However, the role o f protein 
glycosylation for the target antigen recognition by C T L is unknown, and these 
conditions st i l l allow H A synthesis o f various degrees o f glycosylation (32, 33). 
Furthermore, 2-deoxyglucose has profound inh ib i to ry effects on Τ cell-mediated lysis 
(34). 
We first investigated the role o f Μ protein in de termining the pattern o f cross-
reactivity in abortively infected cells. By abortive infection o f L-929 cells w i t h avian 
influenza A strains (FPV) , target cells could be prepared that carry exclusively the 
H A and Ν proteins o f influenza virus in their plasma membranes and are devoid of 
the Μ protein (23). These cells were used as targets for influenza Α-specific C T L . 
W h e n the two influenza-specific effector-cell subsets were tested on these target cells, 
the same pattern o f cross-reactivity could be observed as had been found w i t h target 
cells prepared w i t h other influenza A strains. These results strongly argue against the 
role o f Μ protein as a major antigen for cross-reactive Τ cell populations and indicate 
that these effector cells recognize antigens present on the H A and Ν glycoproteins. 
However, i t remains possible that a low level o f synthesis o f Μ protein that we cannot 
detect occurs in these cells or that other components o f the influenza v i r ion may serve 
as target antigens. 
W i t h respect to the H A specificity o f effector cells and the process o f cross-reactivity, 
controversy exists w i t h regard to the use o f product ively vs. abort ively infected target 
cells (22, 35, 36). I n some cases it has been suggested that incorporat ion o f Μ protein 
into the plasma membrane of cells is even higher in abort ively than i n product ively 
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infected cells (8, 20-22, 35-37). However, the opposite s i tuat ion has been demon­
strated in the model o f the FPV infection o f L-929 cells (23). Perhaps the major 
difference between the results obtained by different authors is a result o f the different 
test conditions; for example, short- vs. long-term cytolyt ic assay and p r i m a r y vs. 
secondary C T L . 
Further evidence for the concept that the envelope glycoproteins carry the target 
antigens recognized by the cross-reactive Τ cell subset has been prov ided by target 
cells that carry the spike proteins o f influenza virus exclusively and none o f the 
influenza internal v i r ion components. T h e preparat ion o f those ar t i f ic ia l target cells 
requires separation o f the envelope proteins from the other v i ra l components, recon-
st i tut ion o f the envelope proteins in to l i p i d bilayers, and fusion o f these ar t i f ic ia l 
vesicles w i t h the plasma membrane to generate target cells lysable by i m m u n e effector 
mechanisms (26). Preparation o f pure envelope proteins from influenza virus s t rain 
A / V i c t o r i a was achieved after d isrupt ion o f the virions i n detergent fol lowed by 
separation o f the proteins on a sucrose gradient. For reconst i tut ion o f the detergent-
solubilized proteins into l i p i d vesicles a mix tu re o f four different phospholipids was 
used, and vesicle formation was achieved by a detergent-di lut ion procedure. 
Reconstituted vesicles were smaller than virions. T h e packing o f spikes i n the l i p i d 
bilayer was found to be very compact by electron microscopy ( E M ) . T h e ra t io o f H A : 
Ν spikes observed by E M was similar to that o f the virus (38). These a r t i f i c ia l ly 
reconstituted vesicles b i n d to the cell surface as revealed by immunofluorescence 
studies (data not shown). However, they do not fuse to any significant extent w i t h the 
plasma membrane as cytolyt ic tests w i t h ant ibody and complement (data not shown) 
and w i t h cytolyt ic Τ cells were negative. 
Vesicle-cell fusion can be achieved w i t h polyethylene glycol ( U . H . Koszinowski . 
Unpubl ished observations.). However, this method was poor ly reproducible , and , 
thus, /?-propiolactone-inactivated S V was used to promote fusion. T h i s me thod offers 
some advantages. The fusion of SV w i t h the cell membrane and its funct ion in cell-
cell fusion requires the presence o f a functionally active fusion prote in (16, 17). T h e 
fusion by SV can be monitored by the act iv i ty o f SV-specific effector cells that are 
(a) selectively specific for SV and do not recognize influenza antigens and (b) also 
require the plasma membrane insertion o f the SV antigens to lyse their targets. By 
using (a) two types o f effector cells, one specific for S V and the other for inf luenza A 
antigens, and (b) target cells prepared either by infection w i t h influenza A virus or by 
incubation w i t h vesicles or mixtures o f vesicles and fusion-active or fusion-inactive 
SV, the experimental system could be control led for both antigenic specificities and 
for fusion. The molecular mechanism(s) responsible for fusion between the virus 
envelope and the plasma membrane and subsequent fusion between the plasma 
membranes and adjacent cells (or adjacent vesicles) in fusion f rom w i t h o u t is s t i l l 
unknown (39). I n this study we have not tr ied to visualize the process o f fusion itself. 
Therefore, the interpretat ion o f the results as a result o f fusion is based on the present 
knowledge about the conditions under wh ich virus-induced cell fusion does occur 
(40). 
Target cells prepared in this way were susceptible to the lysis o f C T L specific for 
the homologous influenza A strain and for C T L w i t h specificity for heterologous 
influenza A strains. T h e absence o f Μ protein in the vesicles p rov ided the formal 
proof that the cross-reactivity observed is not dependent upon the presence o f the Μ 
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prote in . Therefore, the nature o f the antigens seen by this cell popula t ion must be 
solely a result o f the antigens o f the influenza H A and Ν glycoproteins. A l though our 
preparations contained far more H A than Ν glycoproteins, we have not yet determined 
to w h i c h extent bo th envelope proteins contr ibute to the cross-reactive antigenic 
specificity. W o r k is i n progress to prepare vesicles that contain either the H A or the 
N . Studies on the p r i m a r y structure o f the H A glycoprotein o f different subtypes have 
made it possible to dist inguish regions o f variable and o f conserved amino acid 
sequence. Thus it is qui te possible for the H A to present a common structural 
de terminant that cou ld be recognized by cross-reactive Τ cells. I t is also possible that 
the N , w h i c h is k n o w n to show much less antigenic var ia t ion , may carry a common 
determinant (41). Cross-reactivity o f effector cells is also in accord w i t h the observa­
tions o f heterotypic i m m u n i t y (10, 42, 43). 
Recent data indicate that the specificity o f C T L directed to influenza A virus 
antigens can be man ipu la t ed by different in v i t ro rest imulat ion methods. W i t h virions 
of heterologous strains as antigen for rest imulat ion i n v i t ro , the cross-reactive popu­
lations are p r e d o m i n a n t l y triggered (4), whereas rest imulat ion w i t h homologous 
pur i f ied H A raises C T L w i t h specificity for the vira l H A (6, 44). I f one assumes that 
in bo th cases determinants are recognized that are carried by the envelope proteins, 
the prepara t ion o f the antigens as either solubilized spikes or as proteins integrated 
and orientated i n the cell membrane may decide w h i c h Τ ceil popula t ion is triggered. 
T h e observation o f cross-reactivity at the Τ cell level, wh ich seems not to be reflected 
at the Β cell level, is not w i thou t precedent (45, 46). Furthermore, the hypothetical Μ 
prote in specificity o f Τ cells also lacks an explanation because a p r imary influenza 
infection does not no rma l ly cause a significant ant ibody response to the Μ protein 
(2). 
I n assuming that the cross-reactive C T L are not less specific but recognize a 
common antigen shared by the glycoproteins, several explanations can be forwarded: 
(a) T h e number o f Β cell clonotypes (47, 48) to the cross-reactive antigens is normal ly 
too small to be detected, (b) The appropriate determinant cannot be selected by 
antigen-presenting cells for Τ cells that help Β cells (49). (c) The Β cell response to 
these antigens is no rma l ly suppressed (50). I f the possibilities b and /or c do apply, one 
could predict that sensitization w i t h inactivated or pur i f ied virions or vi ra l protein 
preparations should give rise to s imilar ly cross-reactive Β cell clones. The preparation 
o f defined molecules and their ar t i f icial integration i n the plasma membrane may be 
a useful tool for the further analysis o f Τ cell specificity. 
Summary 
T w o populat ions o f cytolyt ic Τ lymphocytes ( C T L ) generated after influenza A 
virus infection can be distinguished into one w i t h specificity for the sensitizing 
hemagglu t in in type and a second w i t h cross-reactivity for antigens induced by other 
type -Α influenza viruses. T h e molecules carrying the antigenic determinants recog­
nized by the cross-reactive C T L were studied. I n L-929 cells abortively infected w i t h 
fowl plague virus, ma t r ix ( M ) protein synthesis is specifically inh ib i ted , whereas the 
envelope glycoproteins, hemagglut in in and neuraminidase, are synthesized and i n ­
corporated in to the plasma membrane. These target cells were lysed by cross-reactive 
C T L . 
T h e envelope proteins o f type A / V i c t o r i a virus were separated from the other 
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vir ion components and reconstituted into l i p i d vesicles that lacked Μ protein that 
subsequently were used to prepare art i f icial target cells. Target-cell formation w i t h 
vesicles was achieved by addi t ion o f fusion-active Sendai virus. These art i f icial target 
cells were also susceptible to lysis by cross-reactive C T L . 
In contrast to previous observations that suggested that the Μ protein o f influenza 
viruses is recognized by these effector cells, we present evidence that the antigencic 
determinants induced by the vira l glycoproteins are recognized. 
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